Journal de microbiologie clinique et antimicrobiens

Journal de microbiologie clinique et antimicrobiens
Libre accès

Volume 8, Problème 1 (2024)

Perspective

Viral Vectors in the Ecological Tapestry of Arboviral Diseases

Qassemi Omar

Partagez cet article

Perspective

Viral Vectors in the Ecological Tapestry of Arboviral Diseases

Qassemi Omar

Partagez cet article

Perspective

Viral Vectors in the Ecological Tapestry of Arboviral Diseases

Qassemi Omar

Partagez cet article

Avis

Black Fungus and its Impact on Human Health

Jesmyn Vuong

Partagez cet article

Avis

Black Fungus and its Impact on Human Health

Jesmyn Vuong

Partagez cet article

Avis

Black Fungus and its Impact on Human Health

Jesmyn Vuong

Partagez cet article

Perspective

Viral Vectors in the Ecological Tapestry of Arboviral Diseases

Qassemi Omar

Partagez cet article

Avis

Black Fungus and its Impact on Human Health

Jesmyn Vuong

Partagez cet article

Perspective

Viral Vectors in the Ecological Tapestry of Arboviral Diseases

Qassemi Omar

Partagez cet article

Avis

Black Fungus and its Impact on Human Health

Jesmyn Vuong

Partagez cet article

Commentaire

Adrenal Fatigue Function and Strategies for Coping with Disorders

Carvey Zusak

Partagez cet article

Commentaire

Adrenal Fatigue Function and Strategies for Coping with Disorders

Carvey Zusak

Partagez cet article

Commentaire

Adrenal Fatigue Function and Strategies for Coping with Disorders

Carvey Zusak

Partagez cet article

Commentaire

Adrenal Fatigue Function and Strategies for Coping with Disorders

Carvey Zusak

Partagez cet article

Commentaire

Adrenal Fatigue Function and Strategies for Coping with Disorders

Carvey Zusak

Partagez cet article

article de recherche

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

Partagez cet article

article de recherche

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

Partagez cet article

article de recherche

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

Partagez cet article

article de recherche

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

Partagez cet article

article de recherche

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

Partagez cet article
Top